about
Advances in structure elucidation of small molecules using mass spectrometryNature's bounty - drug discovery from the seaUltrafast 2D NMR: an emerging tool in analytical spectroscopyMetabolomics beyond spectroscopic databases: a combined MS/NMR strategy for the rapid identification of new metabolites in complex mixturesUse of quadrupole time-of-flight mass spectrometry in the elucidation of unknown compounds present in environmental water.Systematics-guided bioprospecting for bioactive microbial natural products.NMR/MS Translator for the Enhanced Simultaneous Analysis of Metabolomics Mixtures by NMR Spectroscopy and Mass Spectrometry: Application to Human Urine.A Metabolomic Strategy to Screen the Prototype Components and Metabolites of Shuang-Huang-Lian Injection in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry.Metabolite quantitation: detector technology and MIST implications.LC-SPE-NMR-MS: a total analysis system for bioanalysis.From known knowns to known unknowns: predicting in vivo drug metabolites.Looking back through the MIST: a perspective of evolving strategies and key focus areas for metabolite safety analysis.NMR spectroscopy as a tool to close the gap on metabolite characterization under MIST.Approaches for the rapid identification of drug metabolites in early clinical studies.Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides.Mass spectrometry and NMR spectroscopy: modern high-end detectors for high resolution separation techniques--state of the art in natural product HPLC-MS, HPLC-NMR, and CE-MS hyphenations.Nuclear Magnetic Resonance (NMR) Spectroscopy For Metabolic Profiling of Medicinal Plants and Their Products.Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.Recent (2000-2015) developments in the analysis of minor unknown natural products based on characteristic fragment information using LC-MS.Assessing 2D electrophoretic mobility spectroscopy (2D MOSY) for analytical applicationsG.A.M.E.: GPU-accelerated mixture elucidator.Design and construction of a versatile dual volume heteronuclear double resonance microcoil NMR probe.EC-SPE-stripline-NMR analysis of reactive products: a feasibility study.An efficient computer-aided structural elucidation strategy for mixtures using an iterative dynamic programming algorithm.Differential Attenuation of NMR Signals by Complementary Ion-Exchange Resin Beads for De Novo Analysis of Complex Metabolomics Mixtures.A metabolomic strategy to screen the prototype components and metabolites of Qingkailing injection in rat urine by high-performance liquid chromatography with tandem mass spectrometry.Extraction and Quantification of Bioactive Tyrian Purple Precursors: A Comparative and Validation Study from the Hypobranchial Gland of a Muricid Dicathais orbita.Hit Discovery from Natural Products in Pharmaceutical R&DThe importance of hyphenated techniques in the discovery of new lead compounds from nature
P2860
Q28743720-0975C585-F639-4987-BE4D-8EC8F6CBF2C2Q28828257-C83ACF98-AC1A-4F32-BD23-39DB1DC29902Q28828610-01FAD6A2-EB91-44AD-8352-CB6A2190A1B9Q28829138-1A3A0500-3757-4023-97DE-D3F6890409F8Q31135586-1D538675-E2E4-41D3-91EA-5C31AAE92FF6Q34075215-8978E94B-6075-4FDC-843F-0B197D36AF8FQ37281070-8BAF635B-5B19-4FCB-970A-DDF8840C7414Q37639700-94374292-A12C-405C-BF3D-DE075BFC8345Q37810185-6401F923-98AE-4F1B-B1C7-84F321DD5FE8Q37810187-09B1AD85-5751-4C8C-8D66-6F26694F3476Q37810200-CCF9908D-EF54-4997-B711-4A2E81830E93Q37810226-F45681B4-0737-4D30-9827-60728FD15E9BQ37810228-1C67CA01-552C-4DF2-AADF-9DEA01CF70D4Q37830698-D32C7793-C74C-4C9D-9005-E21181DC9375Q38104574-F943409E-D5A0-4A50-9859-20BAF2520765Q38112324-0E2B7FFD-20B4-4666-A4CD-0A9EF72F854FQ38635397-F4607284-C41D-4066-B06A-F9A775EA4964Q38759621-D3E8EAEE-9F50-4BDA-9986-A07A1BF86DE3Q38875972-7FC8931A-D629-4414-B253-423D35E48B43Q41844181-A9FC7030-656E-444A-A6B7-1D03B7F61C0EQ42737143-DB4662B9-5EC1-4276-9574-9172835F5968Q43061557-ED414C50-D1A3-4DC8-8309-11A8BD521A27Q45226630-C1E543A5-E4D3-4615-A6C8-7F6C8647BAE4Q46596317-69430815-1A16-476F-8C9B-839B6681AC07Q48122956-F9740FE1-6013-4916-BE02-CF767794E2C8Q51065585-A98123AC-11B5-49CF-B5A2-740F2F1397B4Q51084134-58233876-8588-4C85-AA1E-F93F24061DCAQ58040749-22C6B30D-3543-4084-9F61-75D9958305DEQ58856067-BB4EB906-75E7-480F-8704-396A5D3A2EEF
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
LC-NMR-MS in drug discovery.
@ast
LC-NMR-MS in drug discovery.
@en
type
label
LC-NMR-MS in drug discovery.
@ast
LC-NMR-MS in drug discovery.
@en
prefLabel
LC-NMR-MS in drug discovery.
@ast
LC-NMR-MS in drug discovery.
@en
P1433
P1476
LC-NMR-MS in drug discovery.
@en
P2093
Olivia Corcoran
P304
P356
10.1016/S1359-6446(03)02749-1
P577
2003-07-01T00:00:00Z